Open includes iron compound, the preferably combination treatment of soluble ferric pyrophosphate (SFP) and citrate compound. It is also disclosed in treatment asiderosis (adjoint or not with anaemia), method including using the combination treatment in the intractable hypoferric anemia of iron and other iron chelating syndrome, and medical composition and kit comprising SFP or another iron compound and citrate compound.
